2025 March Newsletter

March 11, 2025
Download as PDF

Save the date for ACT's Annual Growing Hope Event

Mark your calendars for ACT’s fifth annual Growing Hope fundraiser on Friday, September 12, 2025! Enjoy the scenic beauty of the Winery at Sovereign Estates while enjoying delicious wine, gourmet food, live entertainment and great company, all for an amazing cause. Your presence helps us continue our vital work. Stay tuned for additional event details and registration!

Provide Life-Changing Support as a Corporate Sponsor

Achieving Cures Together invites you to partner with us in making a meaningful impact in patient lives and microbiota research by becoming a corporate sponsor. Join us in our mission to save lives by restoring microbial health. As a corporate sponsor, you have the opportunity to invest improving our community’s health and wellbeing and collaborate with some of the world’s leading research teams in microbial health while elevating your organization’s visibility. Our research partners are leading clinical trials harnessing microbial restoration to treat health conditions including Autism, Food Allergies, Ulcerative Colitis, Cancer Recovery, Crohn’s Disease, and more. To learn more about our sponsorship opportunities, please contact us at info@achievingcures.com. Together we can create lasting change in medical care and patient recovery

Hear from ACT Research Partners in an Upcoming Webinar Opportunity

Medical Pioneers: Our Journey from Fecal Transplants to Live Microbiota Products for Treating Many Health Disorders

Gut-Brain-Axis Therapeutics is hosting a free webinar featuring Alexander Khoruts, MD and Michael Sadowsky, PhD from the University of Minnesota on Wednesday, March 19th 2025 at 7pm Central Time. To register click the link here. This webinar will be recorded, and all registrants will receive a link to the recording. In 2008 Dr. Khoruts treated his first patient suffering with C. difficile infections with stool from her husband. The patient was cured. He then partnered with Prof. Sadowsky to demonstrate that the donor microbes repaired the patient’s decimated microbiome, which was the cause of the infections. The case made medical history, and the treatment became known as ‘fecal microbiota transplantation’ or ‘fecal transplant’. Since then, Drs. Khoruts and Sadowsky continued to work together to make more medical history by developing the first standardized microbiota product composed of highly purified microbes. Subsequently, they developed stable freeze-dried encapsulated and powder products, which are all manufactured in accordance with strict pharmaceutical standards and FDA-approved protocols.

The University of Minnesota Microbiota Therapeutics Program has helped over 8,000 patients suffering with C. difficile infections and is supporting clinical trials across the US for multiple indications, including gut disorders (Ulcerative Colitis, Crohn’s Disease), Cancer therapies, gut-brain disorders (Autism, Hepatic Encephalopathy), and many other disorders.

Register

Achieving Cures Together Race Team

Are you passionate about running and looking for a way to make a difference? ACT has two opportunities for you to run with our race team in 2025. Join ACT’s race team and be a part of a community that is running to improve patient lives. Whether you’re a seasoned marathoner or interested in walking the 5K, you’re welcome to participate on ACT’s race team at any level. Together we can achieve our personal fitness goals and make a lasting impact in medical care.

2025 Colfax Marathon

Join our Run for Nana team in Denver, Colorado on May 17-18th for the Colfax Marathon. Race events include the full marathon, half marathon, Urban 10 Miler and 5K. For registration and race details, visit www.achievingcures.com/2025colfaxmarathon.

2025 Twin Cities Marathon

Registration is open for the 2025 Twin Cities Marathon! Sign up today to secure your spot on ACT’s Twin Cities Marathon on October 5, 2025. For more information and to join our team, visit www.achievingcures.com/2025tcmarathon.

ACT's Latest Blog Post: New Year, New Gut

Many of us are reflecting on our health goals and resolutions. One often overlooked yet essential aspect of health lies within our own gut microbiome—and a key player in that is fiber. Whether you're dealing with digestive issues or simply aiming to feel your best, adding more fiber into your diet is one of the simplest and most effective ways to promote a healthier gut and support overall well-being. Check out ACT’s latest blog post to learn just how critical fiber is for your overall health and explore how you can jump start your digestion with a gut-friendly, fiber-rich diet your microbes will thank you for! www.achievingcures.com/post/new-year-new-gut.

Meet ACT Research Partner: Maradi Pho

Maradi is the Operations Manager at the University of Minnesota Microbiota Therapeutics Program and oversees the manufacturing process for microbiota transplant therapies. Maradi is a critical team player on the Microbiota Therapeutics Program staff, ensuring safe microbiota therapies are available for C. difficile patients and clinical trials. Maradi shared, “It’s incredibly rewarding to turn my childhood curiosity into a profession I love, where I can contribute to understanding and developing innovative approaches to health and disease.” Read Maradi’s story at https://ccaps.umn.edu/story/exploring-gut-microbiome.

10 Year Anniversary

ACT is proud to celebrate 10 incredible years of supporting patient treatments and clinical trials, all thanks to the generosity of the Achieving Cures Together community. Over the past decade, we’ve impacted thousands of lives across the country but we know our work is far from finished. ACT’s current research partnerships include:

  • Advanced Liver Disease (Richmond VA & Virginia Commonwealth University)
  • Alopecia Areata (Columbia University & University of Minnesota)
  • Autism (Arizona State University)
  • C. difficile Infections (University of Minnesota)
  • Congestive Heart Failure (Columbia University & Mayo Clinic)
  • Crohn’s Disease (Multi-Center Trial led by University of Minnesota)
  • Diverticulitis (University of Massachusetts)
  • Gastrointestinal Surgery Recovery (University of Minnesota)
  • Hidradenitis Suppurativa chronic skin condition (University of Minnesota)
  • Multi-Drug Resistance (Emory University & Center for Disease Control)
  • Optimization of Cancer Therapies: Graft Versus Host Disease (Fred Hutchison Cancer Center) and Lung Cancer (University of Minnesota)
  • Peanut Allergies (Boston Children’s Hospital)
  • Pitt Hopkins Syndrome (Arizona State University)
  • Post Microbiota Transplant Diet (University of Minnesota)
  • Primary Sclerosing Cholangitis (University of Minnesota)
  • Pulmonary Arterial Hypertension (University of Minnesota)
  • Ulcerative Colitis (University of Minnesota)

As we look to the future, we ask for your continued partnership. Your contribution ensures we can advance our mission, supporting microbiota research and providing C. difficile patients with treatments. Thank you for helping us improve patient care and save lives.

Donate